These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31337130)

  • 1. Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network.
    Biswas S; Sarabusky M; Chakrabarti S
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31337130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.
    Gong Q; Su G
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNAs: Pivotal Epigenetic Regulators in Diabetic Retinopathy.
    Song Z; He C; Wen J; Yang J; Chen P
    Curr Genomics; 2022 Aug; 23(4):246-261. PubMed ID: 36777876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
    Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
    Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.
    Smit-McBride Z; Morse LS
    Ann Transl Med; 2021 Aug; 9(15):1280. PubMed ID: 34532417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
    Cataldi S; Tramontano M; Costa V; Aprile M; Ciccodicola A
    Antioxidants (Basel); 2022 Oct; 11(10):. PubMed ID: 36290744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
    Shao J; Zhang Y; Fan G; Xin Y; Yao Y
    BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress of lncRNAs in diabetic retinopathy.
    Huang Q; Li J
    Eur J Ophthalmol; 2021 Jul; 31(4):1606-1617. PubMed ID: 33176497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation.
    Chen C; Ding P; Yan W; Wang Z; Lan Y; Yan X; Li T; Han J
    Biochem Pharmacol; 2023 Aug; 214():115643. PubMed ID: 37315816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Ghayour-Mobarhan M; Ferns G; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7839-7846. PubMed ID: 30515789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.
    Pradhan P; Upadhyay N; Tiwari A; Singh LP
    New Front Ophthalmol; 2016; 2(5):192-204. PubMed ID: 28691104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy.
    Mrowicka M; Mrowicki J; Majsterek I
    J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy.
    Biswas S; Thomas AA; Chen S; Aref-Eshghi E; Feng B; Gonder J; Sadikovic B; Chakrabarti S
    Sci Rep; 2018 Apr; 8(1):6526. PubMed ID: 29695738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targets.
    Cai C; Meng C; He S; Gu C; Lhamo T; Draga D; Luo D; Qiu Q
    Cell Biosci; 2022 Nov; 12(1):186. PubMed ID: 36397159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNAs and Proliferative Retinal Diseases.
    Sharma A; Singh NK
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.
    Khullar M; Cheema BS; Raut SK
    Front Endocrinol (Lausanne); 2017; 8():237. PubMed ID: 29085333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
    Wang H; Zhao Y; Chen M; Cui J
    Front Microbiol; 2017; 8():1720. PubMed ID: 28970820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
    Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
    Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.